Abuse liability of the dietary supplement dimethylamylamine

Sean B. Dolan, Michael B. Gatch

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Background: Dimethylamylamine (DMAA) is a component of many dietary supplements and has recently been associated with numerous adverse effects, prompting the US military and World Anti-Doping Agency to ban its use as a supplement. The current study aimed to elucidate the abuse liability profile of DMAA. Methods: Dose-response studies of DMAA were performed with Swiss-Webster mice in locomotor and conditioned place-preference assays. The discriminative stimulus effects of DMAA were investigated in Sprague-Dawley rats trained to discriminate either cocaine or methamphetamine from saline. Results: DMAA produced dose-dependent locomotor depression and fully substituted for cocaine and partially substituted for methamphetamine. In the conditioned place-preference assay, DMAA produced an inverted-U-shaped dose-response curve, with intermediate doses producing significant place preference. Conclusions: The cocaine- and methamphetamine-like discriminative stimulus effects and the conditioned place preference produced by DMAA suggest that is has potential for abuse. These findings in combination with reports of substantial adverse effects of DMAA in humans suggest that control of DMAA may warrant further consideration.

Original languageEnglish
Pages (from-to)97-102
Number of pages6
JournalDrug and Alcohol Dependence
Issue number1
StatePublished - 2015


  • Abuse liability
  • Conditioned place preference
  • Dimethylamylamine
  • Drug discrimination
  • Locomotor activity


Dive into the research topics of 'Abuse liability of the dietary supplement dimethylamylamine'. Together they form a unique fingerprint.

Cite this